Elos Medtech announces planned succession in Memphis
Tim Turner has been appointed to succeed Jodie Gilmore in leading Elos Medtech Memphis. Tim Turner has been with the company for more than 16 years and served in a broad range of capacities with increasing leadership roles including production operations, engineering and business development.
After 10 years serving as the chief executive of Onyx Medical, including 5 years as part of Elos Medtech, Jodie Gilmore will be handing over responsibility to Tim Turner. Tim will take up the position as Managing Director of the Elos Medtech U.S. operation based in Memphis. Jodie Gilmore will stay with Elos Medtech and continue reporting to CEO Jan Wahlström. She will focus more on strategic business development and retain her Orthopedic Business Director role.
The transition of site leadership responsibilities will be an active and collaborative process during the second half of 2020. Tim Turner will officially assume the position of Managing Director on January 1st, 2021.
“Tim has deep knowledge of our industry, our organization, our technology, our processes and our customers," says Jodie Gilmore, Global Business Director Orthopedics. "Having worked closely with Tim for so many years, it gives me great peace of mind to hand over the reins to someone so capable who also shares my passion and dedication for this company.”
“We remain committed to growth and the positive transformation of our business. We are now strengthening our strategic business development focus where Jodie will take the lead. I am delighted that Tim will take on as the Managing Director for our site in Memphis”, says Jan Wahlström, President and CEO.
Elos Medtech is a leading development and production partner for medical devices and components, with a focus on dental and orthopedic implants and instruments. The company operates from facilities in Sweden, Denmark, China and the U.S. The customer base comprises international medical technology companies.
Elos Medtech has more than 550 employees and a turnover of more than SEK 650 million. Elos Medtech has been listed on NASDAQ Stockholm AB since 1989. Elos Medtech’s B share is categorized as a Health Care company on the Small Cap list.
Gothenburg, July 20, 2020
Elos Medtech AB (publ)
For further information, please contact:
Jan Wahlström, President and CEO, +46 70-212 18 89, e-mail: email@example.com
Jodie Gilmore, Global Business Director Orthopedics, +1 901 323 6699, e-mail: firstname.lastname@example.org
For additional information about the Elos Medtech Group, visit www.elosmedtech.com